This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

Viktoriya Dubrovskaya, PhD
Senior Director of Antibody Discovery at AbTherx
Speaker

Profile

Viktoriya is the Senior Director of Antibody Discovery at AbTherx. She is an innovative scientist with an extensive background in antibody discovery, immuno-oncology, infectious diseases, vaccine design, and preclinical drug development. In her most recent role at Amunix Pharmaceuticals, Viktoriya served as the Associate Director of the Discovery Group where she led the preclinical program for conditionally activated T-cell engagers. Viktoriya’s skillset includes protein engineering, phage display, single B-cell cloning, antigen generation (including GPCRs), T-cell engager optimization, and NGS sequencing.

Viktoriya received her PhD from the State Research Center of Virology and Biotechnology in Koltsovo, Russia and her MS from Novosibirsk State University in Novosibirsk, Russia.

Agenda Sessions

  • Atlas™ Mice—A Premier Human Antibody Discovery Platform for Multispecifics and Complex Targets

    12:00pm